Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

1:20AphotoofTaylorTarantofromadetentionmemoreleasedbytheU.S.DistrictCourtfortheDistrictofColumbia.U. 1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel




leisure time

author：hotspot    Page View：34515
Alexis Borisy
Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In
Previous article： Carvykti CAR
Next article： After affirmative action ruling, medical educators look to 'holistic review'